Get started
Canopy Growth CorporationCanopy Growth CorporationCanopy Growth Corporation

Canopy Growth Corporation

No trades
See on Supercharts
Overview Financials News
Ideas
Discussions Forecast Seasonals

11L trade ideas

Canopy Growth Corp (CGC) Shares Drop Below $5Canopy Growth Corp (CGC) Shares Drop Below $5 As the chart indicates, Canopy Growth Corporation (CGC) shares closed below $5 yesterday for the first time since late March 2024. In the spring, the stock price of the cannabis production and distribution company surged amid expectations that the US Drug Enforcement Administration (DEA) might downgrade marijuana from a Schedule I to a Schedule III substance. The decision was indeed made on 30 April, which saw CGC’s share price peak above $14, as investors anticipated that the move would: → accelerate the legalisation of marijuana for both medical and recreational use; → reduce penalties for illegal marijuana trade; → boost profits for companies like Canopy Growth Corporation. However, the reality was different. The Q2 earnings report released on 9 August showed that Canopy Growth Corporation's (CGC) actual performance fell short of analysts' expectations. For instance, gross revenue was $48.3 million (compared to the forecast of $51.2 million and Q1 revenue of $53.7 million). Despite favourable conditions, including a rising stock market in 2024, Canopy Growth Corporation's (CGC) shares have disappointed. A technical analysis of the daily chart for Canopy Growth Corporation (CGC) shows that the stock is trading within a downward channel (marked in red), with the following observations: → Low volatility over the summer (highlighted by an oval) can be interpreted as buyers and sellers agreeing on the stock's fair value, which is typically seen near the median line. → Attempts at growth (indicated by arrows) encountered resistance from the upper boundary (marked with arrows) and were unsuccessful. It's possible that the next contact with the channel's boundary will occur on the lower side. According to TipRanks, none of the analysts recommend buying CGC stock, although their average price target for CGC is $5.93 over the next 12 months – over 20% higher than current levels. This article represents the opinion of the Companies operating under the FXOpen brand only. It is not to be construed as an offer, solicitation, or recommendation with respect to products and services provided by the Companies operating under the FXOpen brand, nor is it to be considered financial advice.
NASDAQ:CGC
by FXOpen
1
Possible Flat Pattern Complete In CGCThe five-wave impulsive reversal from the 6.07 low likely indicates that the wave B flat pattern that has been developing since early April is complete and the next leg higher in wave C has begun. Wave B and the components of wave B display excellent Fibonacci proportion, increasing the validity of the pattern. Price action should remain corrective against the wave B low of 6.07 as price begins to climb higher towards the wave {b} of B high of 14.92. A violation of the 6.07 low would invalidate the wave count.
NASDAQ:CGCLong
by PhiWaveCapital
$CGC near strong seller orderblockNASDAQ:CGC has made a sharp increase recently and the only news published are speculations based on American elections scenarios. Regarding the technicals, there appears to be a strong sellers orderblock between 8.50 and 9.05 and a bearish divergence can be observed with price not breaking above resistance while volume and momentum is decreasing at 15m chart. Recently price broke above 200 ema on the 4h chart. Could this be a possible retracement with a minor correciton before further uptrend or is this the end of the pump phase and possible dump to further downtrend?
NASDAQ:CGC
by chriskokal1
4
Canopy Growth - Last Chance before Explosion! 100X + $NASDAQ:CGHello Guys, Canopy Growth is in my opinion by far one of the most promising and profitable investments existing in 2024. Old All time Highs have been above $500. For me the old run up looks like a Correct 5 Wave Bullish Impulse, which was now followed by a 3 wave ABC down into the lows we have set now. Meaning: The next move is a Wave 3 Impulse, which will catapult Canopy within the next 1-3 years to prices between $800-$1100 as my final target. This is a chance to leave the regular world behind once for all again. Like we did it last year with Solana buying at 20$. Let's get this bag fam - Love you all - Your MrMoMoney NASDAQ:CGC
NASDAQ:CGCLong
by MrMoMoney
5
Puff, Puff, Pass or Crash? Canopy Growth's Fiery ForecastThe Cannabis Rally is Over! Or Is It? Bulls in Canopy Growth haven't had much to laugh about lately after the initial fireworks at the start of the year fizzled out. The last daily bar showed a clear rejection, dampening hopes for a high-flying stock price. However, a look at the Fibonacci levels and the volume profile suggests a prime buying opportunity around $7.50. From there, we can set a relatively tight stop loss, speculating that Canopy Growth's stock price might light up and reach the highs from late April.
NASDAQ:CGCLong
by Ochlokrat
CGC BULLISH EMA 20 CROSSOVER IMMINENT-Earnings next weed### Investment Thesis on Canopy Growth Corporation (CGC) This is not financial advice of any kind. Do your research! 1. Overview and Rationale Canopy Growth Corporation (CGC) is one of the leading players in the cannabis industry. With the potential reclassification of cannabis by the US Federal government, CGC stands to benefit significantly from increased market access, reduced regulatory burdens, and expanded business opportunities. 2. Fundamental Analysis - **Market Position**: CGC has a strong market presence in Canada and is strategically positioned to enter the US market upon federal legalization. - **Revenue Growth**: The company has been showing steady revenue growth with expanding product lines, including recreational and medicinal cannabis, CBD products, and partnerships with beverage companies. - **Strategic Partnerships**: Canopy Growth's partnership with Constellation Brands provides a robust financial backing and enhances its product portfolio with cannabis-infused beverages. - **Potential for US Market Entry**: Reclassification by the US Federal government could open a significant revenue stream for CGC, given the size and growth potential of the US cannabis market. 3. Technical Analysis **Exponential Moving Average (EMA) Analysis** - **EMA 20 Cross Over**: The EMA 20 is on the verge of crossing above the EMA 50. This crossover is typically seen as a bullish signal, indicating a potential upward trend in the stock price. - **Historical Performance**: Previous EMA 20 crossovers have been followed by significant price increases, suggesting a reliable pattern for future predictions. **Triple Dive Pattern** - **Formation**: CGC has recently formed a triple dive pattern, characterized by three successive lows followed by a reversal. - **Implications**: This pattern often indicates a strong support level, suggesting that the stock is unlikely to fall further and may be poised for a bullish reversal. **Keltner Channels** - **Current Position**: CGC's stock price is currently at the lower band of the Keltner Channel, which often indicates that the stock is oversold. - **Potential Movement**: A move back towards the middle or upper band of the Keltner Channel would signal a potential upside, aligning with other bullish indicators. 4. Risk Factors - **Regulatory Risk**: While reclassification is a significant catalyst, it remains uncertain and dependent on political processes. - **Market Volatility**: The cannabis industry is known for its volatility, and CGC is no exception. Investors should be prepared for potential fluctuations. - **Execution Risk**: The ability of CGC to capitalize on US market opportunities will depend on effective execution of its expansion strategy. 5. Investment Strategy Given the combination of fundamental strengths and positive technical indicators, CGC appears to be a compelling investment opportunity. The potential reclassification of cannabis by the US Federal government could serve as a significant catalyst for the stock. The imminent EMA 20 crossover, triple dive pattern, and current position within the Keltner Channels all support a bullish outlook. **Recommended Action**: Initiate a position in CGC stock, with a focus on medium to long-term gains. Monitor technical indicators closely for confirmation of trends and be prepared for potential volatility. --- ### Follow-up Question How would you assess the impact of the potential reclassification of cannabis by the US Federal government on CGC's market strategy and revenue projections? "The mind adapts and converts to its own purposes the obstacle to our acting. The impediment to action advances action. What stands in the way becomes the way." — Marcus Aurelius
NASDAQ:CGCLong
by Stranglemaniac
1
CGC | A Great Opportunity | LONGCanopy Growth Corp. engages in the production, distribution, and sale of cannabis and cannabinoid-based products for both adult-use and medical purposes. The firm operates through the following segments: Canada Cannabis, Rest-of-world Cannabis, Storz and Bickel, BioSteel, This Works, and Other. The Canada Cannabis segment includes the production, distribution, and sale of cannabis, hemp, and cannabis products in Canada. The Rest-of-world Cannabis segment focuses on production and sale of cannabis, hemp, and cannabis products internationally. The Storz and Bickel segment produces and sells vaporizers. The BioSteel segment refers to the sale of consumer packaged goods including sports nutrition beverages, hydration mixes, proteins, and other specialty nutrition products. The This Works segment includes the production and sale of beauty, skincare, wellness, and sleep products, some of which have been blended with hemp-derived CBD isolate. The company was founded by Bruce Linton on August 5, 2009 and is headquartered in Smith Falls, Canada.
NASDAQ:CGCLong
by DivergenceSeeker
4
CGC - Seen This Movie Before ?CGC Something appears to be brewing in weed stocks currently and Canopy is leading with another pump today - up 16%. Does this looks similar to what we've seen before in crypto stocks GALA and VXV ? Notice that off the bear market we get a ripping pump... Then a collapse down makes a lower low and threatens another wave down. But then a sudden recovery prints a SRP Shakeout Reversal Pattern below the low. And that becomes the first pump of the bull market. Looks like the same game could be afoot here 🤨. Not advice
NASDAQ:CGCLong
by dRends35
8
Canopy Growth (The Bearish Case) (If you are smart the better 1)Hello Guys, found this fractal of Canopy from last cycle indicating a last 5th wave down within this ending diagonal could be on the table for Canopy. This would create a slightly Lower low and offer absolutely insane entry prices for the stock. Smart fellas will accumulate more than 1000 Units and even will be able to make a million dollar brining enough patience to the table. Still this is not my primary scenario this is why I already started accumulating no matter the price. Enjoy the ride, we see us in IBIZA, LA or VEGAS in 2027
NASDAQ:CGCShort
by MrMoMoney
2
CGC prepping for generous PRICE GROWTH!NASDAQ:CGC (Canopy Growth Corp) CGC is lowkey trying to cook something based on the recent price action this past 6 weeks. Net positive volume / accumulation has almost doubled this past few days, from 35M to 61m and continuing to rise. Last QTR earnings (August 9, 2023) has aided the significant price recovery - propelling earnings to green territory to 60.3% and revenues to 20%, first green output in the last 5 quarters (15 months). RR ratio on this one looks attractive. Spotted at 0.55 TAYOR. *Safeguard funds always. Factor the muted financial standing of this stock before trading.
NASDAQ:CGCLong
by JSAL
10
Biden Administration Proposes Major Shift in Cannabis PolicyThe Biden administration has taken steps to reclassify marijuana use as a less serious crime. This potential policy change, if finalized, stands to be the most substantial adjustment in federal marijuana regulations in over four decades. The U.S. Department of Justice, overseeing the Drug Enforcement Administration (DEA), has recommended reclassifying cannabis from a Schedule I drug, which denotes substances with a high potential for abuse and no accepted medical use, to a Schedule III drug. This reclassification would reflect a recognition of marijuana's lower potential for physical and psychological dependence compared to other controlled substances. Shares of cannabis companies soared in response to the news, with stocks like Tilray, Trulieve Cannabis Corp, and Green Thumb Industries experiencing surges of over 20% in late afternoon trading. This market reaction underscores the significant financial implications of potential regulatory changes in the cannabis industry. However, it's crucial to note that while the proposed reclassification may lessen the severity of penalties associated with marijuana use, it does not equate to outright legalization for recreational purposes. The shift in classification would likely result in revised sentencing guidelines and potentially open avenues for expanded medical research into cannabis-derived treatments. The proposal is now in the hands of the White House Office of Management and Budget for review and the finalization of the rule-making process. Despite the positive reception from cannabis advocates and investors, the DEA has yet to officially comment on the recommendation. The Biden administration's move reflects a growing shift in public attitudes towards marijuana, with an increasing number of states legalizing its recreational or medicinal use. By reevaluating federal cannabis policies, the administration aims to align with evolving societal norms and address longstanding disparities in drug enforcement practices. Critics argue that the proposed reclassification does not go far enough in addressing broader issues related to drug policy reform, such as racial disparities in marijuana-related arrests and convictions. Nevertheless, proponents view it as a crucial step towards a more rational and equitable approach to cannabis regulation. Technical Outlook Canopy Growth Corporation ( NASDAQ:CGC ) stock is up 62% as a result of the Biden Administration policy on cannabis taking the stock to an overbought region with a Relative Strength Index (RSI) of 73. Further accentuating to the bullish trend is the long "Bullish Harami" candle stick pattern depicted on the daily price chart.
NASDAQ:CGCLong
by DEXWireNews
1
Canopy Growth - First Bullish Push Already Melting FacesHello Guys, to me it looks like canopy has succesfully entered the first 5 wave bigger push to the upside. This Elliot Wave count of mine can be an indication to where the market is likely to go in the immediate short term. Obviously no financial advise. I also See a scenario possible where the market is going to trend a bit higher to then consolidate for a long time (until September or so) This is my secondary scenario. Primary I see us reaching high prices between 30-40$. Regards Mr Mo Money
NASDAQ:CGCLong
by MrMoMoney
1
Canopy Growth Rise Coming Next - Elliot Wave 2. finishedHello guys, according to my Elliot wave count, we could already now have seen the end of the bigger wave 2 which is essential to correct our 5 wave impulse in wave 1. The structure that we have seen in this correction looks like a ABC correction to me with an overshooting B Wave. This means that the C wave is right now finishing and we should sooner than later start the next 5 wave impulse in wave 3 to the upside. So next to come is bullish.
NASDAQ:CGCLong
by MrMoMoney
1